Abstract
Positron emission tomography (PET) with [15O]H2O is the clinical reference standard for assessment of cerebrovascular reactivity (CVR). This molecular imaging technique measures the brain’s uptake of an exogenous, radioactive tracer and fits kinetic models to these measurements to quantify perfusion at rest and after a vasoactive challenge. Single-photon emission computed tomography (SPECT) with [99mTc]-labelled perfusion agents provides relative (non-quantitative) regional cerebral blood flow (rCBF). This chapter describes the theory, acquisition, and modelling aspects of nuclear medicine methods to measure CVR, with focus on [15O]H2O PET. The reliability of the CVR imaging biomarkers and their ability to identify hemodynamic impairment in neurovascular disorders are described. We also discuss the advantages and limitations of the approach and highlight technical advances including hybrid imaging with simultaneous PET/MRI to improve the accuracy and reduce the invasiveness of the methods.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kety SS, Schmidt CF (1948) The nitrous oxide method for the quantitative determination of cerebral blood flow in man: theory, procedure and normal values. J Clin Invest 27:476–483
Xu F, Ge Y, Lu H (2009) Noninvasive quantification of whole-brain cerebral metabolic rate of oxygen (CMRO2) by MRI. Magn Reson Med 62:141–148
Ingvar DH, Lassen NA (1961) Quantitative determination of cerebral blood flow in man. Lancet 2:806–807
Lassen NA, Ingvar DH (1972) Radioisotopic assessment of regional cerebral blood flow. Prog Nucl Med 1:376–409
Kapucu OL, Nobili F, Varrone A et al (2009) EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2. Eur J Nucl Med Mol Imaging 36:2093–2102
Catafau AM (2001) Brain SPECT in clinical practice. Part I: Perfusion. J Nucl Med 42:259–271
Sugawara Y, Kikuchi T, Ueda T et al (2002) Usefulness of brain SPECT to evaluate brain tolerance and hemodynamic changes during temporary balloon occlusion test and after permanent carotid occlusion. J Nucl Med 43:1616–1623
Matsuda H (2007) Role of neuroimaging in Alzheimer’s disease, with emphasis on brain perfusion SPECT. J Nucl Med 48:1289–1300
Spieth ME, Devadas GC, Gauger BS (2004) Procedure guideline for brain death scintigraphy. J Nucl Med 45:922. author reply 922
Kazemi NJ, Worrell GA, Stead SM et al (2010) Ictal SPECT statistical parametric mapping in temporal lobe epilepsy surgery. Neurology 74:70–76
Hoffman EJ, Guerrero TM, Germano G et al (1989) PET system calibrations and corrections for quantitative and spatially accurate images. IEEE Trans Nucl Sci 36:1108–1112
Boellaard R (2009) Standards for PET image acquisition and quantitative data analysis. J Nucl Med 50(Suppl 1):11S–20S
Bremmer JP, van Berckel BN, Persoon S et al (2011) Day-to-day test-retest variability of CBF, CMRO2, and OEF measurements using dynamic 15O PET studies. Mol Imaging Biol 13:759–768
Landau WM, Freygang WH, Roland LP et al (1955) The local circulation of the living brain; values in the unanesthetized and anesthetized cat. Trans Am Neurol Assoc 80:125–129
Raichle ME, Martin WR, Herscovitch P et al (1983) Brain blood flow measured with intravenous H2(15)O. II. Implementation and validation. J Nucl Med 24:790–798
Larsson HB, Courivaud F, Rostrup E et al (2009) Measurement of brain perfusion, blood volume, and blood-brain barrier permeability, using dynamic contrast-enhanced T(1)-weighted MRI at 3 tesla. Magn Reson Med 62:1270–1281
Herscovitch P, Raichle ME (1985) What is the correct value for the brain--blood partition coefficient for water? J Cereb Blood Flow Metab 5:65–69
Huang SC, Mahoney DK, Phelps ME (1987) Quantitation in positron emission tomography: 8. Effects of nonlinear parameter estimation on functional images. J Comput Assist Tomogr 11:314–325
Zhou Y, Huang SC, Bergsneider M (2001) Linear ridge regression with spatial constraint for generation of parametric images in dynamic positron emission tomography studies. IEEE Trans Nucl Sci 48:125–130
Ho D, Feng D (1999) Rapid algorithms for the construction of cerebral blood flow and oxygen utilization images with oxygen-15 and dynamic positron emission tomography. Comput Methods Prog Biomed 58:99–117
Kanno I, Iida H, Miura S et al (1987) A system for cerebral blood flow measurement using an H215O autoradiographic method and positron emission tomography. J Cereb Blood Flow Metab 7:143–153
Treyer V, Jobin M, Burger C et al (2003) Quantitative cerebral H2(15)O perfusion PET without arterial blood sampling, a method based on washout rate. Eur J Nucl Med Mol Imaging 30:572–580
Boellaard R, Knaapen P, Rijbroek A et al (2005) Evaluation of basis function and linear least squares methods for generating parametric blood flow images using 15O-water and positron emission tomography. Mol Imaging Biol 7:273–285
Al-Ibraheem A, Buck A, Krause BJ et al (2009) Clinical applications of FDG PET and PET/CT in head and neck cancer. J Oncol 2009:208725
Shivamurthy VK, Tahari AK, Marcus C et al (2015) Brain FDG PET and the diagnosis of dementia. AJR Am J Roentgenol 204:W76–W85
Bruzzi JF, Munden RF, Truong MT et al (2007) PET/CT of esophageal cancer: its role in clinical management. Radiographics 27:1635–1652
Subhas N, Patel PV, Pannu HK et al (2005) Imaging of pelvic malignancies with in-line FDG PET-CT: case examples and common pitfalls of FDG PET. Radiographics 25:1031–1043
Andersen FL, Ladefoged CN, Beyer T et al (2014) Combined PET/MR imaging in neurology: MR-based attenuation correction implies a strong spatial bias when ignoring bone. NeuroImage 84:206–216
Ladefoged CN, Law I, Anazodo U et al (2016) A multi-centre evaluation of eleven clinically feasible brain PET/MRI attenuation correction techniques using a large cohort of patients. NeuroImage 147:346–359
Zhang K, Herzog H, Mauler J et al (2014) Comparison of cerebral blood flow acquired by simultaneous [15O]water positron emission tomography and arterial spin labeling magnetic resonance imaging. J Cereb Blood Flow Metab 34:1373–1380
Zhang X, Xie Z, Berg E et al (2020) Total-body dynamic reconstruction and parametric imaging on the uEXPLORER. J Nucl Med 61:285–291
Lorthois S, Duru P, Billanou I et al (2014) Kinetic modeling in the context of cerebral blood flow quantification by H2(15)O positron emission tomography: the meaning of the permeability coefficient in Renkin-Crones model revisited at capillary scale. J Theor Biol 353:157–169
Herscovitch P, Raichle ME, Kilbourn MR et al (1987) Positron emission tomographic measurement of cerebral blood flow and permeability-surface area product of water using [15O]water and [11C]butanol. J Cereb Blood Flow Metab 7:527–542
Herzog H, Seitz RJ, Tellmann L et al (1996) Quantitation of regional cerebral blood flow with 15O-butanol and positron emission tomography in humans. J Cereb Blood Flow Metab 16:645–649
Wunderlich G, Knorr U, Stephan KM et al (1997) Dynamic scanning of 15O-butanol with positron emission tomography can identify regional cerebral activations. Hum Brain Mapp 5:364–378
Puig O, Vestergaard MB, Lindberg U et al (2019) Phase contrast mapping MRI measurements of global cerebral blood flow across different perfusion states - a direct comparison with (15)O-H2O positron emission tomography using a hybrid PET/MR system. J Cereb Blood Flow Metab 39:2368–2378
Ibaraki M, Miura S, Shimosegawa E et al (2008) Quantification of cerebral blood flow and oxygen metabolism with 3-dimensional PET and 15O: validation by comparison with 2-dimensional PET. J Nucl Med 49:50–59
Meyer E (1989) Simultaneous correction for tracer arrival delay and dispersion in CBF measurements by the H215O autoradiographic method and dynamic PET. J Nucl Med 30:1069–1078
Kanno I, Miura S, Murakami M (1991) Optimal scan time of oxygen- 15-labeled water cerebral blood flow. J Nucl Med 32:1931–1934
Okazawa H, Yamauchi H, Sugimoto K et al (2001) Effects of acetazolamide on cerebral blood flow, blood volume, and oxygen metabolism: a positron emission tomography study with healthy volunteers. J Cereb Blood Flow Metab 21:1472–1479
Koopman T, Yaqub M, Heijtel DF et al (2019) Semi-quantitative cerebral blood flow parameters derived from non-invasive [(15)O]H2O PET studies. J Cereb Blood Flow Metab 39:163–172
Thomas BP, Liu P, Park DC et al (2014) Cerebrovascular reactivity in the brain white matter: magnitude, temporal characteristics, and age effects. J Cereb Blood Flow Metab 34:242–247
Peng SL, Chen X, Li Y et al (2018) Age-related changes in cerebrovascular reactivity and their relationship to cognition: a four-year longitudinal study. NeuroImage 174:257–262
Deegan BM, Sorond FA, Lipsitz LA et al (2009) Gender related differences in cerebral autoregulation in older healthy subjects. Annu Int Conf IEEE Eng Med Biol Soc 2009:2859–2862
Olah L, Valikovics A, Bereczki D et al (2000) Gender-related differences in acetazolamide-induced cerebral vasodilatory response: a transcranial Doppler study. J Neuroimaging 10:151–156
Coles JP, Fryer TD, Bradley PG et al (2006) Intersubject variability and reproducibility of 15O PET studies. J Cereb Blood Flow Metab 26:48–57
Van Lieshout JJ, Wieling W, Karemaker JM et al (2003) Syncope, cerebral perfusion, and oxygenation. J Appl Physiol (1985) 94:833–848
Kuroda S, Houkin K, Kamiyama H et al (2001) Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it? Stroke 32:2110–2115
Powers WJ, Clarke WR et al (2011) Extracranial-Intracranial Bypass Surgery for Stroke Prevention in Hemodynamic Cerebral Ischemia The Carotid Occlusion Surgery Study Randomized Trial. JAMA 306:1983–1992
Kuhn FP, Warnock G, Schweingruber T et al (2015) Quantitative H2[(15)O]-PET in pediatric moyamoya disease: evaluating perfusion before and after cerebral revascularization. J Stroke Cerebrovasc Dis 24:965–971
Vagal AS, Leach JL, Fernandez-Ulloa M et al (2009) The acetazolamide challenge: techniques and applications in the evaluation of chronic cerebral ischemia. AJNR Am J Neuroradiol 30:876–884
Hosoda K, Kawaguchi T, Shibata Y et al (2001) Cerebral vasoreactivity and internal carotid artery flow help to identify patients at risk for hyperperfusion after carotid endarterectomy. Stroke 32:1567–1573
Derdeyn CP, Videen TO, Yundt KD et al (2002) Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited. Brain 125:595–607
Yamauchi H, Fukuyama H, Nagahama Y et al (1996) Evidence of misery perfusion and risk for recurrent stroke in major cerebral arterial occlusive diseases from PET. J Neurol Neurosurg Psychiatry 61:18–25
Kuwabara Y, Ichiya Y, Sasaki M et al (1995) Time dependency of the acetazolamide effect on cerebral hemodynamics in patients with chronic occlusive cerebral arteries. Early steal phenomenon demonstrated by [15O]H2O positron emission tomography. Stroke 26:1825–1829
Kuwabara Y, Ichiya Y, Sasaki M et al (1998) PET evaluation of cerebral hemodynamics in occlusive cerebrovascular disease pre- and postsurgery. J Nucl Med 39:760–765
Grubb RL, Derdeyn CP, Fritsch SM et al (1998) Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. J Am Med Assoc 280:1055–1060
Bruno A, Adams HP, Biller J et al (1988) Cerebral infarction due to moyamoya disease in young adults. Stroke 19:826–833
Kim SK, Seol HJ, Cho BK et al (2004) Moyamoya disease among young patients: its aggressive clinical course and the role of active surgical treatment. Neurosurgery 54:840–844. discussion 844-846
Kuwabara Y, Ichiya Y, Sasaki M et al (1997) Response to hypercapnia in moyamoya disease. Cerebrovascular response to hypercapnia in pediatric and adult patients with moyamoya disease. Stroke 28:701–707
Kuroda S, Kashiwazaki D, Hirata K et al (2014) Effects of surgical revascularization on cerebral oxygen metabolism in patients with Moyamoya disease: an 15O-gas positron emission tomographic study. Stroke 45:2717–2721
Glodzik L, Randall C, Rusinek H et al (2013) Cerebrovascular reactivity to carbon dioxide in Alzheimer’s disease. J Alzheimers Dis 35:427–440
Stefani A, Sancesario G, Pierantozzi M et al (2009) CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline in Alzheimer’s and mixed dementia. J Neurol Sci 283:109–115
Jagust WJ, Eberling JL, Reed BR et al (1997) Clinical studies of cerebral blood flow in Alzheimer’s disease. Ann N Y Acad Sci 826:254–262
Kimura Y, Kitagawa K, Oku N et al (2010) Blood pressure lowering with valsartan is associated with maintenance of cerebral blood flow and cerebral perfusion reserve in hypertensive patients with cerebral small vessel disease. J Stroke Cerebrovasc Dis 19:85–91
Penfield W (1933) The evidence for a cerebral vascular mechanism in epilepsy. Ann Intern Med 7:303–310
Kwan P, Brodie MJ (2000) Early identification of refractory epilepsy. N Engl J Med 342:314–319
Dwivedi R, Ramanujam B, Chandra PS et al (2017) Surgery for drug-resistant epilepsy in children. N Engl J Med 377:1639–1647
Knowlton RC, Lawn ND, Mountz JM et al (2004) Ictal SPECT analysis in epilepsy. Neurology 63:10–15
Grunwald F, Menzel C, Pavics L et al (1994) Ictal and interictal brain SPECT imaging in epilepsy using technetium-99m-ECD. J Nucl Med 35:1896–1901
Chen T, Guo L (2016) The role of SISCOM in preoperative evaluation for patients with epilepsy surgery: a meta-analysis. Seizure 41:43–50
Newey CR, Wong C, Irene Wang Z et al (2013) Optimizing SPECT SISCOM analysis to localize seizure-onset zone by using varying z scores. Epilepsia 54:793–800
Ogasawara K, Ito H, Sasoh M et al (2003) Quantitative measurement of regional cerebrovascular reactivity to acetazolamide using 123I-N-isopropyl-p-iodoamphetamine autoradiography with SPECT: validation study using H2 15O with PET. J Nucl Med 44:520–525
Jae Seung K, Dae Hyuk M, Geun Eun K et al (2000) Acetazolamide stress brain-perfusion SPECT predicts the need for carotid shunting during carotid endarterectomy. J Nucl Med 41:1836–1841
Lee HY, Jin CP, Dong SL et al (2004) Efficacy assessment of cerebral arterial bypass surgery using statistical parametric mapping and probabilistic brain atlas on basal/acetazolamide brain perfusion SPECT. J Nucl Med 45:202–206
Cikrit DF, Dalsing MC, Harting PS et al (1997) Cerebral vascular reactivity assessed with acetazolamide single photon emission computer tomography scans before and after carotid endarterectomy. Am J Surg 174:193–197
Morinaga A, Ono K, Ikeda T et al (2010) A comparison of the diagnostic sensitivity of MRI, CBF-SPECT, FDG-PET and cerebrospinal fluid biomarkers for detecting Alzheimer’s disease in a memory clinic. Dement Geriatr Cogn Disord 30:285–292
Mehdorn HM, Gerhard L, Muller SP et al (1992) Clinical and cerebral blood flow studies in patients with intracranial hemorrhage and amyloid angiopathy typical of Alzheimer’s disease. Neurosurg Rev 15:111–116
O’Brien JT, Firbank MJ, Davison C et al (2014) 18F-FDG PET and perfusion SPECT in the diagnosis of Alzheimer and Lewy body dementias. J Nucl Med 55:1959–1965
Raji CA, Tarzwell R, Pavel D et al (2014) Clinical utility of SPECT neuroimaging in the diagnosis and treatment of traumatic brain injury: a systematic review. PLoS One 9:e91088
Zuckier LS, Kolano J (2008) Radionuclide studies in the determination of brain death: criteria, concepts, and controversies. Semin Nucl Med 38:262–273
Werner P, Barthel H, Drzezga A et al (2015) Current status and future role of brain PET/MRI in clinical and research settings. Eur J Nucl Med Mol Imaging 42:512–526
Catana C, Drzezga A, Heiss WD et al (2012) PET/MRI for neurologic applications. J Nucl Med 53:1916–1925
Ssali T, Anazodo UC, Thiessen JD et al (2018) A noninvasive method for quantifying cerebral blood flow by hybrid PET/MRI. J Nucl Med 59:1329–1334
Ishii Y, Thamm T, Guo J et al (2020) Simultaneous phase-contrast MRI and PET for noninvasive quantification of cerebral blood flow and reactivity in healthy subjects and patients with cerebrovascular disease. J Magn Reson Imaging 51:183–194
Su Y, Arbelaez AM, Benzinger TL et al (2013) Noninvasive estimation of the arterial input function in positron emission tomography imaging of cerebral blood flow. J Cereb Blood Flow Metab 33:115–121
Khalighi MM, Deller TW, Fan AP et al (2018) Image-derived input function estimation on a TOF-enabled PET/MR for cerebral blood flow mapping. J Cereb Blood Flow Metab 38:126–135
Andersen JB, Lindberg U, Olesen OV et al (2019) Hybrid PET/MRI imaging in healthy unsedated newborn infants with quantitative rCBF measurements using (15)O-water PET. J Cereb Blood Flow Metab 39:782–793
Fan AP, Guo J, Khalighi MM et al (2017) Long-delay arterial spin labeling provides more accurate cerebral blood flow measurements in moyamoya patients: a simultaneous positron emission tomography/MRI study. Stroke 48:2441–2449
Puig O, Henriksen OM, Vestergaard MB et al (2020) Comparison of simultaneous arterial spin labeling MRI and (15)O-H2O PET measurements of regional cerebral blood flow in rest and altered perfusion states. J Cereb Blood Flow Metab 40:1621–1633
Okazawa H, Higashino Y, Tsujikawa T et al (2018) Noninvasive method for measurement of cerebral blood flow using O-15 water PET/MRI with ASL correlation. Eur J Radiol 105:102–109
Chen KT, Gong E, de Carvalho Macruz FB et al (2020) Ultra-Low-Dose (18)F-Florbetaben Amyloid PET Imaging Using Deep Learning with Multi-Contrast MRI Inputs. Radiology 296:E195
Kaplan S, Zhu YM (2019) Full-dose PET image estimation from low-dose PET image using deep learning: a pilot study. J Digit Imaging 32:773–778
Chen DYT, Ishii Y, Fan AP et al (2020) Predicting PET cerebrovascular reserve with deep learning by using baseline MRI: a pilot investigation of a drug-free brain stress test. Radiology 296:627–637
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Fan, A.P., Puig Calvo, O. (2022). Molecular Imaging of Cerebrovascular Reactivity. In: Chen, J., Fierstra, J. (eds) Cerebrovascular Reactivity. Neuromethods, vol 175. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1763-2_3
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1763-2_3
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1762-5
Online ISBN: 978-1-0716-1763-2
eBook Packages: Springer Protocols